TyDiQA1.0

The Typologically Different Question Answering Dataset

Predictions

Scores

Trastuzumab

The Typologically Different Question Answering Dataset

The drug was first discovered by scientists including Dr. Axel Ullrich and Dr. H. Michael Shepard at Genentech, Inc. in South San Francisco, CA.[44] Earlier discovery about the neu oncogene by Robert Weinberg's lab [45] and the monoclonal antibody recognizing the oncogenic receptor by Mark Greene's lab [46] also contributed to the establishment of HER2 targeted therapies. Dr. Dennis Slamon subsequently worked on trastuzumab's development. A book about Dr. Slamon's work was made into a television film called Living Proof, that premiered in 2008. Genentech developed trastuzumab jointly with UCLA, beginning the first clinical trial with 15 women in 1992.[47] By 1996, clinical trials had expanded to over 900 women, but due to pressure from advocates based on early success, Genentech worked with the FDA to begin a lottery system allowing 100 women each quarter access to the medication outside the trials.[48] Herceptin was Fast-tracked by the FDA and gained approval in September 1998.